This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
iRobot (IRBT) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
iRobot's (IRBT) Q3 results might reflect a healthy demand for products, a surge in e-commerce and improved international businesses. Pandemic woes and promotional expenses are to ail.
Parker-Hannifin (PH) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Parker-Hannifin (PH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Top Ranked Income Stocks to Buy for October 16th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, October 16th.
Middleby Stock Up 26.4% in 3 Months: What's Driving it?
by Zacks Equity Research
Middleby (MIDD) stands to benefit from a strong product portfolio, improving order trends, solid backlog and acquisitions. However, its debt level remains high.
Top Ranked Income Stocks to Buy for October 15th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, October 15th.
Tetra Tech Secures $24M Single-Award Contract From USAID
by Zacks Equity Research
Tetra Tech's (TTEK) contract with USAID will help the latter in executing the Regional Water and Vulnerable Environment Activity in Central Asia.
Parker-Hannifin Gains From Acquisitions Amid Pandemic Scare
by Zacks Equity Research
Parker-Hannifin (PH) is likely to benefit from strength across its end markets and acquired assets. The coronavirus outbreak-led market downturn and high debt level pose concerns.
Reasons Why it is Worth Investing in Colfax (CFX) Stock Now
by Zacks Equity Research
Colfax (CFX) to benefit from growth opportunities in the Fabrication Technology and Medical Technology segments. Also, business in multiple end markets and cost-reduction actions are other tailwinds.
FLS vs. XYL: Which Stock Is the Better Value Option?
by Zacks Equity Research
FLS vs. XYL: Which Stock Is the Better Value Option?
Flowserve Reshapes Debt With Senior Notes Issue & Redemption
by Zacks Equity Research
Flowserve (FLS) issues senior notes worth $500 million and uses proceeds to redeem Euro-denominated senior notes. These actions are likely to help in restructuring the company's debt profile.
Flowserve Offers Senior Notes, To Use Funds for Note Buybacks
by Zacks Equity Research
Flowserve (FLS) prices senior notes offerings worth $500 million and commences tender offer for Euro-denominated senior notes.
Flowserve (FLS) Up 2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Flowserve (FLS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Near-Term Outlook Bleak for Industrial Manufacturing Stocks
by Zacks Equity Research
The Manufacturing - General Industrial industry is facing the coronavirus scares, escalating costs and other issues. Higher orders and recovery in manufacturing activities will likely benefit.
Are Investors Undervaluing Flowserve (FLS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
FLS vs. IEX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
FLS vs. IEX: Which Stock Is the Better Value Option?
Flowserve (FLS) Beats on Q2 Earnings & Sales, Updates View
by Zacks Equity Research
Flowserve's (FLS) Q2 earnings reflect the impacts of weak sales generation, forex woes and improved operating margin. It expects earnings in the second half to improve from the first half level.
Flowserve (FLS) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Flowserve (FLS) delivered earnings and revenue surprises of 82.76% and 3.83%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Industrial Stock Q2 Earnings Due on Jul 30: SWK, XYL & More
by Avisekh Bhattacharjee
The impacts of the coronavirus outbreak, cost-related woes and other headwinds are expected to get reflected in the results of the majority of industrial stocks in Q2.
Flowserve (FLS) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Solid backlog, strength in the thermal solar market and realignment program are expected to have boosted Flowserve's (FLS) Q2 performance. The pandemic-led market downturn is expected to have ailed.
Analysts Estimate Flowserve (FLS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Flowserve (FLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Consider Buying Flowserve (FLS) Now
by Zacks Equity Research
Flowserve (FLS) benefits from its solid backlog level, investments in organic growth, solid liquidity position and cost-reduction measures.
FLS vs. XYL: Which Stock Is the Better Value Option?
by Zacks Equity Research
FLS vs. XYL: Which Stock Is the Better Value Option?
Flowserve (FLS) Displays Strong Prospects Despite Risks
by Zacks Equity Research
Flowserve (FLS) benefits from its strong backlog level, investments in enhancing organic growth and robust liquidity position. However, weakness in oil and gas end markets remains concerning.
Why Is Flowserve (FLS) Up 15.2% Since Last Earnings Report?
by Zacks Equity Research
Flowserve (FLS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Flowserve (FLS) Declines 46.1% YTD: What's Affecting It?
by Zacks Equity Research
Flowserve (FLS) suffers from a soft demand environment, rising expenses and several other issues.